reglab/housing_qa huggingface dataset:
NY Pub Health L § 3397-D (2021)
2021 New York Laws PBH - Public Health Article 33-A - Controlled Substances Therapeutic Research Act 3397-D - State Patient Qualification Review Board; Composition; Powers and Duties.

§  3397-d.  State  patient  qualification  review  board; composition; powers and duties.  1. The commissioner shall appoint  a  state  patient qualification  review  board  of  no  less than three nor more than five members. The state patient qualification review board shall be comprised of:  (a) A  physician  licensed  to  practice  medicine  in  New  York  and certified by the American board of ophthalmology;  (b)  A  physician  licensed  to  practice  medicine  in  New  York and certified by the American board of internal medicine and also  certified in the subspecialty of medical oncology;  (c)  A  physician  licensed  to  practice  medicine  in  New  York and certified  in  psychiatry  by  the  American  board  of  psychiatry  and neurology; and  (d) Any other members that the commissioner may deem necessary.   2.  Members  of  such  board  shall  be appointed for three year terms except that the term of those first appointed shall be arranged so  that as  nearly  as  possible  an  equal  number  shall terminate annually. A vacancy occurring during a term shall be filled by an appointment by the commissioner for the unexpired term. The  commissioner  shall  designate the  chairman  of the board. Any member may be removed from the board at the pleasure of the commissioner.   3. Each member of the board shall receive  up  to  one  hundred  fifty dollars  as prescribed by the commissioner for each day devoted to board work not to exceed forty-five hundred dollars in any one year, and shall be reimbursed for necessary expenses.
NY Pub Health L § 3397-E (2021)
2021 New York Laws PBH - Public Health Article 33-A - Controlled Substances Therapeutic Research Act 3397-E - Patient Participation in Program; Procedure.

§  3397-e.  Patient  participation  in  program;  procedure.    1. Any   hospital may establish a hospital patient qualification review committee   subject to the rules and regulations promulgated by the commissioner.  A   hospital may designate a hospital human research review committee as set   forth in section twenty-four hundred forty-four of this chapter to serve   as a hospital patient qualification review committee.2.  Any  physician  may  recommend  a patient for participation in the   Antonio G. Olivieri controlled substances therapeutic  research  program   to  the hospital patient qualification review committee for the hospital   wherein such patient has received medical treatment.3. The hospital patient qualification review  committee  shall  review   each  recommendation  and  shall submit approved patient applications to   the state patient qualification review board.4. The state patient  qualification  review  board  shall  review  all   physician  applicants  for the Antonio G. Olivieri controlled substances   therapeutic research program and certify  or  refuse  to  certify  their   participation in the program.5.  The  state  patient  qualification  review board may delegate to a   hospital patient qualification review committee the authority to approve   or disapprove a patient's participation in such program.6. A patient shall not be eligible  to  participate  in  such  program   without  the approval of the state patient qualification review board or   the hospital patient qualification review committee  delegated  pursuant   to subdivision five of this section.7.  The  hospital  human  research  review committee shall review each   human research project proposed  hereunder  and  shall  certify  to  the   hospital  patient qualification review committee that such project meets   the requirements of this  article  and  article  twenty-four-A  of  this   chapter.
NY Pub Health L § 3397-F (2021)
2021 New York Laws PBH - Public Health Article 33-A - Controlled Substances Therapeutic Research Act 3397-F - Antonio G. Olivieri Controlled Substances Therapeutic Research Program; Distribution.

§  3397-f.  Antonio  G.  Olivieri  controlled  substances  therapeutic   research program;  distribution.    1.  The  commissioner  shall  obtain   marijuana  through  whatever means he deems most appropriate, consistent   with regulations promulgated by the national institute  on  drug  abuse,   the food and drug administration and the drug enforcement administration   and pursuant to the provisions of this article.2.  If, within a reasonable time, the commissioner is unable to obtain   controlled substances pursuant to subdivision one of  this  section,  he   shall conduct an inventory of available sources of such drugs, including   but  not  limited  to  the  New  York  state  police  bureau of criminal   investigation and local law enforcement officials. Said inventory  shall   be   for  the  purpose  of  determining  the  feasibility  of  obtaining   controlled substances for use  in  the  program.  Upon  conducting  said   inventory, the commissioner shall contract with the available source for   the receipt of controlled substances.3.  The commissioner shall cause such marijuana to be transferred to a   hospital for distribution to the  certified  patient  pursuant  to  this   article.
NY Pub Health L § 3398-A (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-A - Rulemaking Authority.

* § 3398-a. Rulemaking    authority.   The   commissioner   may   make   regulations pursuant to this article for the  processing,  distribution,   marketing, transportation and sale of cannabinoid hemp and hemp extracts   used for human consumption, which may include, but not be limited to:1.    Specifying    forms,    establishing   application,   reasonable   administration and renewal fees, or license duration;2. Establishing the qualifications  and  criteria  for  licensing,  as   authorized by law;3. The books and records to be created and maintained by licensees and   lawful procedures for their inspection;4. Any reporting requirements;5.  Methods  and  standards  of  processing,  labeling,  packaging and   marketing  of  cannabinoid  hemp,  hemp  extract  and  products  derived   therefrom;6.  Procedures  for how cannabinoid hemp, hemp extract or ingredients,   additives, or products derived therefrom can be deemed as acceptable for   sale in the state;7.  Provisions  governing  the  modes  and  forms  of  administration,   including inhalation;8.  Procedures  for determining whether cannabinoid hemp, hemp extract   or  ingredients,  additives,  or  products  derived  therefrom  produced   outside   the   state  or  within  the  state  meet  the  standards  and   requirements of this article and can therefore be sold within the state;9. Procedures for the granting, cancellation, revocation or suspension   of licenses, consistent with the state administrative procedures act;10.  Restrictions  governing  the   advertising   and   marketing   of   cannabinoid hemp, hemp extract and products derived therefrom; and11. Any other regulations necessary to implement this article.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-B (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-B - Cannabinoid Hemp Processor License.

* § 3398-b. Cannabinoid  hemp processor license. 1. Persons processing   cannabinoid hemp or hemp extract used for human consumption, whether  in   intermediate  or  final  form, shall be required to obtain a cannabinoid   hemp processor license from the department.2. A  cannabinoid  hemp  processor  license  authorizes  one  or  more   specific  activities  related to the processing of cannabinoid hemp into   products used for human consumption, whether in  intermediate  or  final   form,  and  the  distribution  or  sale thereof by the licensee. Nothing   herein shall prevent  a  cannabinoid  hemp  processor  from  processing,   extracting  and  processing  hemp  products  not  to  be  used for human   consumption.3. Persons authorized to grow hemp pursuant to article twenty-nine  of   the  agriculture  and  markets  law  are  not  authorized  to  engage in   processing of cannabinoid hemp  or  hemp  extract  without  first  being   licensed as a cannabinoid hemp processor under this article.4.  This  article  shall  not  apply  to  hemp, cannabinoid hemp, hemp   extracts or products derived therefrom  that  are  not  used  for  human   consumption.    This  article  also shall not apply to hemp, cannabinoid   hemp, hemp extracts or products derived therefrom that have been  deemed   generally recognized as safe pursuant to federal law.5.  The  commissioner  shall have the authority to set reasonable fees   for such license, to limit the activities permitted by such license,  to   establish  the  period  during  which  such license is authorized, which   shall be two years or more, and to make rules and regulations  necessary   to implement this section.6.  Any  person  holding an active research partnership agreement with   the department of agriculture and markets, authorizing  that  person  to   process cannabinoid hemp, shall be awarded licensure under this section,   provided  that  the  research  partner  is  actively performing research   pursuant to such agreement and is able to  demonstrate  compliance  with   this  article,  as  determined  by  the  department, after notice and an   opportunity to be heard.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-C (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-C - Cannabinoid Hemp Retailer License.

* § 3398-c. Cannabinoid  hemp  retailer  license. 1. Retailers selling   cannabinoid hemp, in final form to consumers within the state, shall  be   required  to  obtain  a  cannabinoid  hemp  retailer  license  from  the   department.2. The commissioner shall have the authority to  set  reasonable  fees   for  such  license, to establish the period during which such license is   authorized, which shall be one year or  more,  and  to  make  rules  and   regulations necessary to implement this section.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-D (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-D - Cannabinoid License Applications.

* § 3398-d. Cannabinoid  license  applications. 1. Persons shall apply   for a license under this article by submitting  an  application  upon  a   form  supplied  by  the department, providing all the relevant requested   information, verified by the applicant or an  authorized  representative   of the applicant.2.  A  separate  license  shall be required for each facility at which   processing or retail sales are  conducted;  however,  an  applicant  may   submit one application for separate licensure at multiple locations.3.  Each  applicant  shall remit with its application the fee for each   requested license, which shall be a reasonable fee.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-E (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-E - Information to Be Requested in Applications or Licenses.

* § 3398-e. Information  to be requested in applications for licenses.   1.   The commissioner may specify  the  manner  and  form  in  which  an   application  shall  be  submitted  to the department for licensure under   this article.2. The commissioner may adopt regulations establishing  what  relevant   information shall be included on an application for licensure under this   article.   Such   information  may  include,  but  is  not  limited  to:   information about the applicant's  identity;  ownership  and  investment   information,  including  the corporate structure; evidence of good moral   character; financial statements; information about the  premises  to  be   licensed; information about the activities to be licensed; and any other   relevant information specified in regulation.3.  All  license  applications  shall be signed by the applicant if an   individual, by a managing partner if a limited liability company, by  an   officer  if  a  corporation,  or  by all partners if a partnership. Each   person signing such application  shall  verify  it  as  true  under  the   penalties of perjury.4.  All license applications shall be accompanied by a check, draft or   other forms of payment as the department may require or authorize in the   reasonable amount required by this article for such license.5. If there be any change, after the filing of the application or  the   granting,  modification  or renewal of a license, in any of the material   facts required to be set  forth  in  such  application,  a  supplemental   statement  giving  notice  of such change, duly verified, shall be filed   with the department within ten days after such change. Failure to do so,   if willful and deliberate, may be grounds for revocation of the license.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-F (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-F - Fees.

* § 3398-f. Fees.  The  department  may  charge licensees a reasonable   license fee. Such fee may be based on the activities  permitted  by  the   license,  the amount of cannabinoid hemp or hemp extract to be processed   or extracted by the licensee, the gross annual receipts of the  licensee   for  the previous license period, or any other factors reasonably deemed   appropriate by the department.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-G (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-G - Selection Criteria.

* § 3398-g. Selection  criteria. 1. The applicant, if an individual or   individuals, shall furnish  evidence  of  the  individual's  good  moral   character, and if an entity, the applicant shall furnish evidence of the   good   moral  character  of  the  individuals  who  have  or  will  have   substantial responsibility for the licensed or authorized  activity  and   those  in  control  of  the  entity,  including principals, officers, or   others with such control.2. The applicant shall furnish evidence of the applicant's  experience   and  competency,  and  that  the  applicant  has  or  will have adequate   facilities, equipment, process controls, and security to undertake those   activities for which licensure is sought.3. The applicant shall furnish evidence of his, her or its ability  to   comply with all applicable state and local laws, rules and regulations.4.  If  the commissioner is not satisfied that the applicant should be   issued a license, the commissioner shall notify the applicant in writing   of the specific reason or reasons for denial.5. No license pursuant to this article may be issued to an  individual   under the age of eighteen years.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-H (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-H - License Renewal.

* § 3398-h. License  renewal. 1. Each license, issued pursuant to this   article, may be renewed upon application therefor by  the  licensee  and   the  payment of the reasonable fee for such license as specified by this   article.2. In the case  of  applications  for  renewals,  the  department  may   dispense   with   the  requirements  of  such  statements  as  it  deems   unnecessary in view of those contained in the application made  for  the   original license.3.  The  department  shall  provide  an application for renewal of any   license issued under this article not less than ninety days prior to the   expiration of the current license.4. The department may only issue a renewal license upon receipt of the   specified renewal application and renewal fee from  a  licensee  if,  in   addition  to  the  selection  criteria  set  out  in  this  article, the   licensee's license is not under suspension and has not been revoked.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-I (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-I - Form of License.

* § 3398-i. Form  of license. Licenses issued pursuant to this article   shall specify:1. The name and address of the licensee;2. The activities permitted by the license;3. The land, buildings  and  facilities  that  may  be  used  for  the   licensed activities of the licensee;4.  A  unique license number issued by the department to the licensee;   and5. Such other information as the commissioner shall deem necessary  to   assure compliance with this chapter.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-J (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-J - Transferability; Amendment to License; Change in Ownership or Control.

* § 3398-j. Transferability; amendment to license; change in ownership   or  control. 1. Licenses issued under this article are not transferable,   absent written consent of the commissioner.2. Upon application of a licensee, a license may be amended to add  or   delete permitted activities.3.  A  license shall become void by a change in ownership, substantial   corporate change or change of location without prior written approval of   the commissioner. The commissioner may  make  regulations  allowing  for   certain types of changes in ownership without the need for prior written   approval.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-K (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-K - Granting, Suspending or Revoking Licenses.

* § 3398-k. Granting,  suspending  or  revoking  licenses.  After  due   notice and  an  opportunity  to  be  heard,  established  by  rules  and   regulations, the commissioner may decline to grant a new license, impose   conditions  or  limits with respect to the grant of a license, modify an   existing license or decline to renew  a  license,  and  may  suspend  or   revoke  a license already granted after due notice and an opportunity to   be  heard,  as  established  by  rules  and  regulations,  whenever  the   commissioner finds that:1. A material statement contained in an application is or was false or   misleading;2.  The applicant or licensee, or a person in a position of management   and control thereof or of the licensed  activity,  does  not  have  good   moral   character,   necessary   experience   or   competency,  adequate   facilities,  equipment,  process  controls,  or  security  to   process,   distribute, transport or sell cannabinoid hemp, hemp extract or products   derived therefrom;3. After appropriate notice and opportunity, the applicant or licensee   has  failed or refused to produce any records or provide any information   required  by  this  article  or  the  regulations  promulgated  pursuant   thereto;4.  The  licensee has conducted activities outside of those activities   permitted on its license; or5. The applicant or licensee, or any officer,  director,  partner,  or   any  other  person  exercising  any  position  of  management or control   thereof or of the licensed activity has willfully failed to comply  with   any  of the provisions of this article or regulations under it and other   laws of this state applicable to the licensed activity.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-L (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-L - Record Keeping and Tracking.

* § 3398-l. Record keeping and tracking. Every licensee shall keep, in   such  form  as the commissioner may direct, such relevant records as may   be required pursuant to regulations under this article.* NB Repealed 6 months after the full cannabis control  board  created   by Article 2 of the cannabis law has been appointed
NY Pub Health L § 3398-M (2021)
2021 New York Laws PBH - Public Health Article 33-B - Regulation of Cannabinoid Hemp and Hemp Extract 3398-M - Packaging and Labeling of Cannabinoid Hemp and Hemp Extract.

* § 3398-m. Packaging  and  labeling  of  cannabinoid  hemp  and  hemp   extract.  1. Cannabinoid hemp processors shall be  required  to  provide   appropriate  label  warning  to  consumers,  and  restricted from making   unapproved label claims, as determined by the department, concerning the   potential impact on or benefit to human health resulting from the use of   cannabinoid hemp, hemp extract and products derived therefrom for  human   consumption,  which labels shall be affixed to those products when sold,   pursuant to rules and regulations that the department may adopt.2. The department may, by rules and regulations, require processors to   establish a code, including, but not limited to QR code, for labels  and   establish  methods  and  procedures for determining, among other things,   serving sizes or dosages for cannabinoid hemp, hemp extract and products   derived therefrom, active cannabinoid concentration  per  serving  size,   number  of  servings  per  container,  and  the growing region, state or   country of origin  if  not  from  the  United  States.  Such  rules  and   regulations may require an appropriate fact panel that incorporates data   regarding serving sizes and potency thereof.3.  The  packaging,  sale,  or  possession  of  products  derived from   cannabinoid hemp or hemp extract used for human consumption not  labeled   or  offered  in  conformity with regulations under this section shall be   grounds for the seizure or quarantine of the product, the imposition  of   a  civil  penalty  against  a processor or retailer, and the suspension,   revocation or  cancellation  of  a  license,  in  accordance  with  this   article.* NB  Repealed  6 months after the full cannabis control board created   by Article 2 of the cannabis law has been appointed